Multi-level intervention research to improve transitions from pediatric to adult care for childhood/adolescent cancer survivors. Clinical trial optional.
Eligibility Criteria:
-
U.S. institutions (universities, nonprofits, for-profits, governments); foreign organizations not eligible.
-
Foreign components of U.S. applicants allowed.
-
PD/PI with appropriate expertise; eRA Commons ID required.
-
Human subjects research; multidisciplinary teams encouraged.
Funding Details:
-
Mechanism: R01 (new or resubmission; clinical trial optional).
-
Budget: up to 499,000 USD direct costs/year.
-
Duration: up to 5 years.
-
NCI plans ~10M USD total across FY25–26 to fund up to ~12 awards (across prior/current issuance).
Deadline:
-
Open: September 17, 2025.
-
Due: October 17, 2025 (5:00 PM local time).
-
LOI: ~30 days before due date.
Where to Go for Further Information:
- Program details.
-
Scientific contact: Lynn S. Adams, PhD — [email protected]
-
Grants management: Crystal Wolfrey — [email protected]
-
General help: [email protected]